Literature DB >> 9694698

A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.

A Zivelin1, N Rosenberg, S Faier, N Kornbrot, H Peretz, C Mannhalter, M H Horellou, U Seligsohn.   

Abstract

The polymorphism G20210A in the 3' untranslated region of the prothrombin gene is associated with an increased level of factor II activity and confers a twofold to fivefold increase in the risk for venous thromboembolism. Among Caucasian populations, the prevalence of factor II G20210A heterozygotes is 1% to 6%, whereas in non-Caucasian populations it is very rare or absent. The aim of the present study was to discern whether factor II G20210A originated from a single or recurrent mutational events. Allele frequencies of four dimorphisms spanning 16 of 21 kb of the factor II gene were determined in 133 unrelated Caucasian subjects of Jewish, Austrian, and French origins who bore factor II G20210A (10 homozygotes and 123 heterozygotes) and 110 Caucasian controls. Remarkable differences in the allele frequencies for each dimorphism were observed between the study groups (P = .0007 or less), indicating strong linkage disequilibrium and suggesting a founder effect. Indeed, a founder haplotype was present in 68% of 20210A mutant alleles and only in 34% of 20210G normal alleles (P < .0001). These data strongly support a single origin for factor II G20210A that probably occurred after the divergence of Africans from non-Africans and of Caucasoid from Mongoloid subpopulations. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694698

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Prevalence of the prothrombin G20210A polymorphism in the Lebanese population: use of a reverse hybridization strip assay approach.

Authors:  Amira S Sabbagh; Georges Ibrahim; Ziad Kanaan; Dina M R Shammaa; Rabab Abdel Khalek; Mona Ghasham; Layal Greige; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2007-12-08       Impact factor: 2.316

2.  Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.

Authors:  G A Diaz; B D Gelb; N Risch; T G Nygaard; A Frisch; I J Cohen; C S Miranda; O Amaral; I Maire; L Poenaru; C Caillaud; M Weizberg; P Mistry; R J Desnick
Journal:  Am J Hum Genet       Date:  2000-04-21       Impact factor: 11.025

Review 3.  Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype. A paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  David Bosler; Joan Mattson; Domnita Crisan
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

4.  Trombophilic screening for nonarteritic anterior ischemic optic neuropathy.

Authors:  Valeria Nagy; Zita Steiber; Lili Takacs; Gyorgy Vereb; Andras Berta; Zsuzsanna Bereczky; Gyorgy Pfliegler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

5.  Prothrombotic risk factors and antithrombotic therapy in children with ischemic stroke.

Authors:  Azza A Eltayeb; Gamal A Askar; Naglaa H Abu Faddan; Taghreed M Kamal
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

Review 6.  Genetic predictors of response to photodynamictherapy.

Authors:  Francesco Parmeggiani; Donato Gemmati; Ciro Costagliola; Francesco Semeraro; Paolo Perri; Sergio D'Angelo; Mario R Romano; Katia De Nadai; Adolfo Sebastiani; Carlo Incorvaia
Journal:  Mol Diagn Ther       Date:  2011-08-01       Impact factor: 4.074

7.  Pediatric thromboembolism: a national survey in Japan.

Authors:  Akira Ishiguro; Chibueze Chioma Ezinne; Nobuaki Michihata; Hisaya Nakadate; Atsushi Manabe; Masashi Taki; Midori Shima
Journal:  Int J Hematol       Date:  2016-08-18       Impact factor: 2.490

8.  Impact of Prothrombotic Risk Factors in a Cohort of Egyptian Hemophilia A Patients.

Authors:  Mona Salah El-Din Hamdy; Aml Soliman Nasr; Manal Mohamed Makhlouf; Zainab Ali El-Saadany; Magy Samir; Dalia Saber Morgan
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

9.  Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.

Authors:  Rana Dajani; Raja Fatahallah; Abdelrahman Dajani; Mohammad Al-Shboul; Yousef Khader
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

Review 10.  Human gene mutation in pathology and evolution.

Authors:  D N Cooper
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.